ONO-1110

DRUG5 trials

Sponsors

Ono Pharmaceutical Co., Ltd.

Conditions

FibromyalgiaHunner Type Interstitial CystitisMajor Depressive Disorder (MDDPostherpetic NeuralgiaSocial Anxiety Disorder (SAD)

Phase 2

A Study of ONO-1110 in Patients With Postherpetic Neuralgia

CompletedNCT06708416

Ono Pharmaceutical Co., Ltd.Postherpetic Neuralgia

Start: 2025-02-12End: 2026-05-11Updated: 2026-07-15

A Clinical Study of ONO-1110 in Patients With Hunner Type Interstitial Cystitis

CompletedNCT06752603

Ono Pharmaceutical Co., Ltd.Hunner Type Interstitial Cystitis

Start: 2025-04-02End: 2026-06-12Updated: 2026-07-07

A Clinical Study of ONO-1110 in Patients With Fibromyalgia

CompletedNCT06752590

Ono Pharmaceutical Co., Ltd.Fibromyalgia

Start: 2025-03-26End: 2026-05-30Updated: 2026-07-07

A Study of ONO-1110 in Patients With Major Depressive Disorder

CompletedNCT06792136

Ono Pharmaceutical Co., Ltd.Major Depressive Disorder (MDD

Start: 2025-01-16End: 2026-04-09Updated: 2026-07-08

A Study of ONO-1110 in Patients With Social Anxiety Disorder

CompletedNCT06805565

Ono Pharmaceutical Co., Ltd.Social Anxiety Disorder (SAD)

Start: 2025-01-31End: 2026-05-25Updated: 2026-07-08